Heart Failure POC & LOC Devices Market Size, Share & Trends Analysis Report By Test Type, By Technology (Microfluidics, Array-based Systems), By End-use (Clinics, Hospitals, Home), And Segment Forecasts, 2019 - 2025

Published: Oct, 2019 | Pages: 122 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global heart failure POC & LOC devices market size is expected to reach USD 129.69 million by 2025 and is projected to grow at a CAGR of 16.2%, according to a new report by Grand View Research, Inc. A paradigm shift in diagnostic sectors from late-stage disease detection to early identification of diseases as a viable strategy to curb rising healthcare costs has driven the market. This shift has led to the development of disposable and low-cost LOC devices that integrate various sensors and associated accessories in a single space for detection of the cardiac biomarkers from a single specimen to evaluate the risk of having a heart attack.

Furthermore, the development of predictive modeling techniques-based decision support software to analyze the data measured by the LOC assays to enable therapy monitoring is one of the key market drivers. Also, ongoing studies on the application of saliva-based nano-biochip tests for measuring myocardial infarction is driving organic revenue growth.

POC testing exhibits potential savings across various settings, including hospitals, general practice, and remote areas. In the U.S., the employment of POC devices resulted in a 20% decrease in hospital admissions to the chest pain unit, resulting in substantial savings in time and costs.

In the cardiac observation unit (U.S.), the implementation of POC troponin testing helped reduce hospital stays, decrease admission rates, and remove the need for multiple costly procedures, resulting in 25% cost saving per patient. Furthermore, the integration of smartphones and apps in POC diagnostics for managing the cardiac health of an individual is one of the significant innovations in Heart Failure POC & LOC Devices market.

Further key findings from the report suggest:

• Proteomic analysis includes products that test protein markers, such as troponin, myoglobin, and Creatine Kinase MB Isoenzyme (CK-MB)

• This segment accounted for the leading revenue share, as most of the currently available products are based on testing of protein markers

• Increasing implementation of microfluidic LOC technology for assessing putative biomarkers has led to the largest revenue share of this technology

• Microfluidic technologyhas been implemented for various biological applications, such as immunohybridization techniques, enzymatic assays, PCR, and others

• Clinics that include physician's office, pharmacy & retail clinics, urgent care clinics, and non-practice clinics are the key revenue generating end-users

• A high usage rate of POC devices by general practitioners for rapid investigation, deciding early treatment, timely referral, and less uncertainty for patients has driven the revenue growth through clinics

• The U.S. dominated the global Heart Failure POC & LOC devices market owing to the presence of a substantial number of primary care clinics that are deploying POC cardiac marker test as a measure for early detection of heart failure

• Expanding urbanization and increasing geriatric population underpin the demand for robust and improved healthcare services such as POC diagnostics for routine cardiac health monitoring in Asian countries

• Moreover, initiatives are undertaken for training young healthcare personnel about POC cardiac troponin T/cardiac troponin I biomarkers

• This, in turn, is anticipated to result in the surging adoption rate of POC devices in Asian countries

• Abbott, Siemens Healthineers, Danahar, and F. Hoffmann-La Roche Ltd are some key participants operating in the space

• Companies are engaged in mergers and acquisitions of emerging players. Acquisition of Alere by Abbott, Beckman Coulter, Inc by Danahar, and Accriva Diagnostics by Instrumentation Laboratory are some examples of acquisitions in this market

 Table of Contents

Chapter 1 Executive Summary

Chapter 2 Research Methodology
                   2.1 Information Procurement
                       2.1.1 Purchased database:
                       2.1.2 GVR's Internal Database
                       2.1.3 Secondary sources:
                       2.1.4 Third Party Perspective:
                       2.1.5 Primary Research:
                   2.2 Data Analysis
                   2.3 Market Formulation & Validation
                   2.4 Region Wise Market Calculation
                       2.4.1 Region wise market: Base estimates
                       2.4.2 Global market: CAGR calculation
                       2.4.3 Region based segment share calculation

Chapter 3 Heart Failure POC & LOC Devices Market Variables, Trends, & Scope
                   3.1 Market Segmentation & Scope
                   3.2 Heart Failure POC & LOC Devices Market- Market Dynamics
                       3.2.1 Market driver analysis
                           3.2.1.1 Advancement in saliva-based POC testing
                           3.2.1.2 Expanding POC test portfolio for targeting wide array of cardiac markers
                           3.2.1.3 Introduction of CLIA-waived tests
                           3.2.1.4 Rise in funding from government and private institutions
                           3.2.1.5 Increase in the demand for outpatient services and introduction of technologically advanced products
                           3.2.1.6 Rise in geriatric population
                       3.2.2 Market restraint analysis
                           3.2.2.1 High procedure costs
                           3.2.2.2 Presence of ambiguous regulatory framework
                       3.2.3 Market opportunity analysis
                           3.2.3.1 Funding for heart and cardiovascular disease
                           3.2.3.2 Investments in diagnostic sector
                           3.2.3.3 Technological advancements in POC diagnostics
                           3.2.3.4 Rapidly growing diagnostics market in Asia Pacific
                   3.3 Penetration & Growth Prospect Mapping for Technology, 2018
                   3.4 Heart Failure POC & LOC Devices Market - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
                   3.5 Industry Analysis - Porter's
                   3.6 Pricing Analysis
                   3.7 Qualitative analysis on the cost paid by the patients
                       3.7.1 Reimbursement framework
                           3.7.1.1 U.S. Reimbursement Scenario
                           3.7.1.2 Canada Reimbursement Scenario

Chapter 4 Heart Failure POC & LOC Devices Market Categorization: Test Type Estimates & Trend Analysis
                   4.1 Heart Failure POC & LOC Devices Market: Test Type Movement Analysis
                   4.2 Proteomic Testing
                       4.2.1 Global proteomic testing market, 2014 - 2025 (USD Million)
                   4.3 Metabolomic Testing
                       4.3.1 Global metabolomic testing market, 2014 - 2025 (USD Million)
                   4.4 Genomic Testing
                       4.4.1 Global genomic testing market, 2014 - 2025 (USD Million)

Chapter 5 Heart Failure POC & LOC Devices Market Categorization: Technology Estimates & Trend Analysis
                   5.1 Heart Failure POC & LOC Devices Market: Technology Movement Analysis
                   5.2 Microfluidics
                       5.2.1 Global microfluidic based heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
                   5.3 Array-based Systems
                       5.3.1 Global array-based systems market, 2014 - 2025 (USD Million)
                   5.4 Others
                       5.4.1 Global other technologies-based heart failure POC & LOC devices market, 2014 - 2025 (USD Million)

Chapter 6 Heart Failure POC & LOC Devices Market Categorization: End-use Estimates & Trend Analysis
                   6.1 Heart Failure POC & LOC Devices Market: End-use Movement Analysis
                   6.2 Clinics
                       6.2.1 Global heart failure POC & LOC devices market for clinics, 2014 - 2025 (USD Million)
                   6.3 Hospitals
                       6.3.1 Global heart failure POC & LOC devices market for hospitals, 2014 - 2025 (USD Million)
                   6.4 Home
                       6.4.1 Global heart failure POC & LOC devices market for home, 2014 - 2025 (USD Million)
                   6.5 Assisted Living Healthcare Facilities
                       6.5.1 Global heart failure POC & LOC devices market for assisted living healthcare facilities, 2014 - 2025 (USD Million)
                   6.6 Laboratory
                       6.6.1 Global heart failure POC & LOC devices market for laboratories, 2014 - 2025 (USD Million)

Chapter 7 Heart Failure POC & LOC Devices Market Categorization: Regional Estimates & Trend Analysis, by Test Type, Technology, & End-use
                   7.1 Heart Failure POC & LOC Devices Market Share by Region, 2018 & 2025
                   7.2 North America
                       7.2.1 North America heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
                       7.2.2 U.S.
                           7.2.2.1 U.S. heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.2.2.2 U.S. heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.2.2.3 U.S. heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)
                       7.2.3 Canada
                           7.2.3.1 Canada heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.2.3.2 Canada heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.2.3.3 Canada heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)
                   7.3 Europe
                       7.3.1 Europe heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
                       7.3.2 Germany
                           7.3.2.1 Canada heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.3.2.2 Canada heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.3.2.3 Canada heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)
                       7.3.3 UK
                           7.3.3.1 Canada heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.3.3.2 Canada heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.3.3.3 Canada heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)
                   7.4 Asia Pacific
                       7.4.1 Asia Pacific heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
                       7.4.2 Japan
                           7.4.2.1 Japan heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.4.2.2 Japan heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.4.2.3 Japan heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)
                       7.4.3 China
                           7.4.3.1 China heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.4.3.2 China heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.4.3.3 China heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)
                   7.5 Latin America
                       7.5.1 Latin America heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
                       7.5.2 Brazil
                           7.5.2.1 Brazil heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.5.2.2 Brazil heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.5.2.3 Brazil heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)
                   7.6 Middle East & Africa
                       7.6.1 Middle East & Africa heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
                       7.6.2 South Africa
                           7.6.2.1 South Africa heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.6.2.2 South Africa heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.6.2.3 South Africa heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)
                       7.6.3 Saudi Arabia
                           7.6.3.1 Saudi Arabia heart failure POC & LOC devices market, by test type, 2014 - 2025 (USD Million)
                           7.6.3.2 Saudi Arabia heart failure POC & LOC devices market, by technology, 2014 - 2025 (USD Million)
                           7.6.3.3 Saudi Arabia heart failure POC & LOC devices market, by end-use, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
                   8.1 Strategy Framework
                   8.2 Market Participation Categorization
                   8.3 Company Profiles
                       8.3.1 Abbott Laboratories
                           8.3.1.1 Company overview
                           8.3.1.2 Alere, Inc.
                           8.3.1.3 Financial performance
                           8.3.1.4 Product benchmarking/Product portfolio
                           8.3.1.5 Strategic initiatives
                       8.3.2 Siemens Healthineers
                           8.3.2.1 Company overview
                           8.3.2.2 Financial performance
                           8.3.2.3 Product benchmarking/product portfolio
                           8.3.2.4 Strategic initiatives
                       8.3.3 Danaher
                           8.3.3.1 Company overview
                           8.3.3.2 Beckman Coulter, Inc.
                           8.3.3.3 Radiometer Medical ApS
                           8.3.3.4 HemoCue AB
                           8.3.3.5 Financial performance
                           8.3.3.6 Product benchmarking/product portfolio
                           8.3.3.7 Strategic initiatives
                       8.3.4 Instrumentation Laboratory
                           8.3.4.1 Company overview
                           8.3.4.2 Accriva Diagnostics
                           8.3.4.3 International Technidyne Corporation (ITC)
                           8.3.4.4 Financial performance
                           8.3.4.5 Product benchmarking/product portfolio
                           8.3.4.6 Strategic initiatives
                       8.3.5 F. Hoffmann-La Roche Ltd.
                           8.3.5.1 Company overview
                           8.3.5.2 Financial performance
                           8.3.5.3 Product benchmarking/product portfolio
                           8.3.5.4 Strategic initiatives
                       8.3.6 bioMérieux S.A.
                           8.3.6.1 Company overview
                           8.3.6.2 Financial performance
                           8.3.6.3 Product benchmarking/product portfolio
                           8.3.6.4 Strategic initiatives
                       8.3.7 Abaxis, Inc.
                           8.3.7.1 Company overview
                           8.3.7.2 Financial performance
                           8.3.7.3 Product benchmarking/product portfolio
                           8.3.7.4 Strategic initiatives
                       8.3.8 Quidel Corporation
                           8.3.8.1 Company overview
                           8.3.8.2 Financial performance
                           8.3.8.3 Product benchmarking/product portfolio
                           8.3.8.4 Strategic initiatives
                       8.3.9 Jant Pharmacal Corporation
                           8.3.9.1 Company overview
                           8.3.9.2 Financial performance
                           8.3.9.3 Product benchmarking/product portfolio
                           8.3.9.4 Strategic initiatives
                       8.3.10 Trinity Biotech
                           8.3.10.1 Company overview
                           8.3.10.2 Financial performance
                           8.3.10.3 Product benchmarking/product portfolio
                           8.3.10.4 Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 POC devices for detection of diseases through specific salivary biomarkers
TABLE 3 POC devices for testing of Tn, CK-MB, and Myoglobin
TABLE 4 Funding programs for heart disease & strokes
TABLE 5 Cost analysis: POC kit
TABLE 6 Cost analysis: POC consumables
TABLE 7 Cost analysis: POC instruments
TABLE 8 Cost analysis: Service
TABLE 9 North America heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 10 North America heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 11 North America heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 12 U.S. heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 13 U.S. heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 14 U.S. heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 15 Canada heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 16 Canada heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 17 Canada heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 18 Europe heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 19 Europe heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 20 Europe heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 21 Germany heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 22 Germany heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 23 Germany heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 24 UK heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 25 UK heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 26 UK heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 27 Asia Pacific heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 29 Asia Pacific heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 30 Japan heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 31 Japan heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 32 Japan heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 33 China heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 34 China heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 35 China heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 36 Latin America heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 37 Latin America heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 38 Latin America heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 39 Brazil heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 40 Brazil heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 41 Brazil heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 42 MEA heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 43 MEA heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 44 MEA heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 45 South Africa heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 46 South Africa heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 47 South Africa heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
TABLE 48 Saudi Arabia heart failure POC & LOC devices market estimates & forecasts, by test type, 2014 - 2025 (USD Million)
TABLE 49 Saudi Arabia heart failure POC & LOC devices market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 50 Saudi Arabia heart failure POC & LOC devices market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market segmentation & scope
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Shift in POC molecular diagnostic trends
FIG. 12 Number of persons aged 80 or over (Millions), 2019 versus 2050
FIG. 13 Global percentage of population, by age group, 2000 and 2050
FIG. 14 Population over the age of 65, by region, 2010 and 2050
FIG. 15 Market restraint relevance analysis (Current & future impact)
FIG. 16 Investors interest in diagnostic products or services based on LSN Investor Platform, as of December 7, 2015
FIG. 17 Diagnostic investors, by geographic footprint, as of December 7, 2015
FIG. 18 Technological advancements in POC arena
FIG. 19 Future opportunities with regard to products in the market
FIG. 20 Factors driving Asian diagnostic sectors
FIG. 21 Penetration & growth prospect mapping for technology, 2018
FIG. 22 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 23 Porter's Five Forces Analysis
FIG. 24 The annual cost comparison for the Methodist Clinical Laboratory Services of Indianapolis
FIG. 25 Heart failure POC & LOC devices market: Test type outlook key takeaways
FIG. 26 Heart failure POC & LOC devices market: Test Type movement analysis
FIG. 27 Global proteomic testing market, 2014 - 2025 (USD Million)
FIG. 28 Global metabolomic testing market, 2014 - 2025 (USD Million)
FIG. 29 Global genomic testing market, 2014 - 2025 (USD Million)
FIG. 30 Heart failure POC & LOC devices market: Technology outlook key takeaways
FIG. 31 Heart failure POC & LOC devices market: Technology movement analysis
FIG. 32 Global microfluidic based heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 33 Global array-based systems market, 2014 - 2025 (USD Million)
FIG. 34 Global other technologies based heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 35 Heart failure POC & LOC devices market: End-use outlook key takeaways
FIG. 36 Heart failure POC & LOC devices market: End-use movement analysis
FIG. 37 Global heart failure POC & LOC devices market for clinics, 2014 - 2025 (USD Million)
FIG. 38 Global heart failure POC & LOC devices market for hospitals, 2014 - 2025 (USD Million)
FIG. 39 Global heart failure POC & LOC devices market for home, 2014 - 2025 (USD Million)
FIG. 40 Global heart failure POC & LOC devices market for assisted living healthcare facilities, 2014 - 2025 (USD Million)
FIG. 41 Global heart failure POC & LOC devices market for laboratories, 2014 - 2025 (USD Million)
FIG. 42 Regional market place: Key takeaway
FIG. 43 Heart failure POC & LOC devices regional outlook, 2018 & 2025
FIG. 44 North America heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 45 U.S. heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 46 Canada heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 47 Europe heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 48 Germany heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 49 UK heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 50 Asia Pacific heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 51 Japan heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 52 China heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 53 Latin America heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 54 Brazil heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 55 Middle East & Africa heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 56 South Africa heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 57 Saudi Arabia heart failure POC & LOC devices market, 2014 - 2025 (USD Million)
FIG. 58 Strategy framework
FIG. 59 Participant categorization